300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in Asia (October 2023)

The most active venture capital funds and angel investors investing in Asia Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Asia Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Hillhouse Capital Group
VC Fund
6 China, United States, India Series B, Series A, Series C Biotechnology, Health Care, Software $1.4M–$310M
Prox Ventures
VC Fund
5 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care
Sequoia Capital China
VC Fund
5 China, United States, Australia Series A, Series B, Series C Health Care, Biotechnology, Artificial Intelligence $4M–$200M
EFung Capital
VC Fund
4 China, United States, India Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $1.4M–$84M
Osaka University Venture Capital
VC Fund
4 Japan Seed, Series A Health Care, Biotechnology, Manufacturing $6.9M–$233M
Huagai Capital
VC Fund
4 China, United States, Hong Kong Series A, Series B, Angel Health Care, Biotechnology, Medical $412k–$90M
Qiming Venture Partners
VC Fund
3 China, United States, Hong Kong Series B, Series A, Series C Health Care, Medical, Biotechnology $4.1M–$148M
Legend Capital
VC Fund
3 China, United States, South Korea Series B, Series A, Series C Health Care, Biotechnology, Medical $2.7M–$200M
Entrepreneurship Relay Group
VC Fund
3 China Series A, Angel, Series C Medical, Life Science, Biotechnology
EDBI
VC Fund
3 United States, Singapore, China Series C, Series B, Series D Biotechnology, Software, Health Care $7M–$350M
Anzu Partners
VC Fund
3 United States, Canada, Spain Series A, Series B Biotechnology, Manufacturing, Software $872k–$22M
Mitsubishi UFJ Capital
VC Fund
3 Japan, United States, China Series B, Series A Software, Health Care, Information Technology $11M–$330M
SMBC Venture Capital
VC Fund
3 Japan, United States, Mexico Series A, Series B Health Care, Information Technology, Software $18M–$357M
Nippon Venture Capital
VC Fund
3 Japan, United States Series A, Seed Software, Health Care, Information Technology $6.8M–$112M
BioVenture
VC Fund
3 China, United States, Taiwan Series A, Series B, Series C Health Care, Medical, Biotechnology $2.7M–$58M
ULTIMA
VC Fund
2 China Angel, Series A Hardware, Software, Agriculture
WuXi AppTec
VC Fund
2 United States, China, Israel Series A, Series B, Series C Biotechnology, Pharmaceutical, Health Care $5.9M–$100M
Highlight Capital
VC Fund
2 China, United States, Portugal Series A, Series B, Series C Health Care, Biotechnology, Medical $2.7M–$200M
MiraclePlus
VC Fund
2 China, United States, Singapore Seed, Angel, Pre-Seed Artificial Intelligence, Software, Information Technology $200k–$3M
Eisai
VC Fund
2 Japan, United States, China Series A, Series C Biotechnology, Health Care, Medical
Orient Securities Capital Investment
VC Fund
2 China Series A, Series D, Series C Health Care, Manufacturing, Software $1.4M–$69M
Green Pine Capital Partners
VC Fund
2 China, United States, Canada Series A, Angel, Series B Artificial Intelligence, Manufacturing, Software $412k–$150M
Oriental Fortune Capital
VC Fund
2 China, United States Series A, Series B, Seed Software, Information Technology, E-Commerce $412k–$100M
Nissay Capital
VC Fund
2 Japan, United States Seed, Series A Health Care, Internet, Medical $925k–$69M
Loyal Valley Capital
VC Fund
2 China, United States, Hong Kong Series C, Series B, Series A Biotechnology, Health Care, Pharmaceutical $14M–$279M
BOHE Angel Fund
VC Fund
2 China Angel, Seed, Series A Health Care, Medical, Biotechnology
CentreGold Capital
VC Fund
2 United States, China, Canada Seed, Series A, Angel Internet, Medical Device, Artificial Intelligence $549k–$3M
Incubate Fund
VC Fund
2 Japan, United States, India Seed, Series A Software, Information Technology, E-Commerce $500k–$165M
Mizuho Capital
VC Fund
2 Japan, United States, China Series A, Series B Information Technology, Software, Internet $7.8M–$343M
SBI Investment
VC Fund
2 Japan, South Korea, United States Series B, Series A Financial Services, Information Technology, Software $5.9M–$302M
Huimei Capital
VC Fund
2 China, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Medical $10M–$220M
Sherpa Venture Capital
VC Fund
2 China, United States, Kenya Series A, Series B, Series C Biotechnology, Health Care, Medical $6.9M–$151M
CD Capital
VC Fund
2 China, United States Series A, Series B, Angel Health Care, Biotechnology, Medical Device $412k–$34M
Senshu Ikeda Capital
VC Fund
2 Japan Seed, Series A Software, Internet, Information Technology $5.6M–$89M
Eight Roads Ventures
VC Fund
2 United States, China, India Series B, Series A, Series C Software, Health Care, Information Technology $5.4M–$100M
Bits x Bites
VC Fund
2 China, Israel, Singapore Series A, Seed, Series B Biotechnology, Food and Beverage, Food Processing $4k–$38M
Real Tech Japan
VC Fund
2 Japan, Singapore, Austria Series A, Seed Manufacturing, Biotechnology, Robotics $4.8M–$233M
Med-Fine Capital
VC Fund
2 China, United States Series A, Series B, Seed Health Care, Biotechnology, Medical $2.7M–$50M
Lilly Asia Ventures
VC Fund
2 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $11M–$275M
Lucion
VC Fund
2 China Series A, Seed, Series B Biotechnology, Medical, Manufacturing $1.4M–$522M
ASBV
VC Fund
2 China Series A, Seed, Angel Health Care, Medical, Biotechnology $412k–$30M
Anhui High-tech Industry Investment
VC Fund
1 China Angel Medical, Health Care, Life Science
Tsing-Yuan Capital
VC Fund
1 China, United States Series A, Angel, Series B Manufacturing, Health Care, E-Commerce $412k–$14M
Kaitai Capital
VC Fund
1 China, United States Series A, Angel, Seed Biotechnology, Health Care, Pharmaceutical $412k–$21M
SDIC Venture Capital
VC Fund
1 China, United States, Hong Kong Series B, Series A, Series C Manufacturing, Biotechnology, Health Care $2.7M–$275M
Hiroaki Kitano
Angel
1 Japan, United States Seed, Angel, Debt Financing Health Care, Information Technology, Fitness $6.9M–$41M
Alibaba Group
VC Fund
1 China, United States, India Series A, Series B, Series C E-Commerce, Internet, Software $1.4M–$600M
Kunlun Capital
VC Fund
1 China Seed, Series A, Series B Biotechnology, Medical, Genetics $20M–$27M
Fujifilm
VC Fund
1 Japan, Israel, United States Series A, Series B Biotechnology, Medical Device, Medical $49M–$412M
Hana Financial Investment
VC Fund
1 South Korea, Singapore, India Series A, Seed Information Technology, FinTech, Financial Services $860k–$25M
Access all 50 investors in Asia Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Hillhouse Capital Group
VC Fund · Changyang, Beijing, China · 6 investments in Asia Life Science startups, 16 in the past 12 months

Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 312
  • Round size: Series A $1.4M–$120M; Series B $14M–$230M; Series C $14M–$310M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Immorna — Immorna specializes in the production of RNA-based therapeutics.
  • Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
  • Deep Vision Intelligence — Deep Vision Intelligence is a developer of embedded machine vision products.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 5 investments in Asia Life Science startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 46
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • VacV Biotech — VacV Biotherapeutics develops an oncolytic virus platform based on the vaccinia virus. The platform genetically modifies the oncolytic virus, which improves its specificity to tumors, reduces neurotoxicity, enhances the therapeutic effect, and greatly increases the production of extracellular enveloped virus (EEV). It has higher safety andefficiency and can be administered by intravenous injection.
  • HROCT LITT Medtech — HROCT LITT Medtech has developed the unique SNP(Smart Needle Probe) needle imaging, assembled as a catheter, which OD is smaller than 1/5 of the traditional invasive OCT catheter, while the depth and resolution are all multiple times of the traditional invasive OCT catheter, achieving 1um level to supply the histopathology needed microimaging.The fiber could be compatible with different kinds of biopsy needles to access the targets, and also could be coupled with a specific laser to achieve OCT situ diagnosis and laser ablation. Its technology provides revolutionary solutions to neurosurgery, interventional pulmonology, neurovascular, nephropathy, mammary gland, cardiac, GI, and other fields.
Show all investments...

Sequoia Capital China
VC Fund · Beijing, Beijing, China · 5 investments in Asia Life Science startups, 56 in the past 12 months

We help founders build enduring companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Australia

Investor stats

  • Total investments: 643
  • Round size: Series A $4M–$90M; Series B $11M–$172M; Series C $25M–$200M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • FUE Bioscience — FUE Bioscience is a medical robot R&D business that specializes in microsurgery above the head and neck. It continues to develop a product matrix of fully intelligent, high-precision, and anthropomorphic surgical robots based on the platform of macro-micro-controlled humanoid dual-arm robots.
  • Life Wilderness — Life Wilderness reimagines human-computer interaction and is linked to the transportation and travel industries.
  • Xintu Heterogeneous — Xintu Heterogeneous offers data storage solutions for heterogeneous computing.
Show all investments...

EFung Capital
VC Fund · Shenzhen, Guangdong, China · 4 investments in Asia Life Science startups, 7 in the past 12 months

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 42
  • Round size: Series A $1.4M–$76M; Series B $15M–$84M; Series C $14M–$69M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Turno — Turno Finance makes owning EV very affordable. Turno Club is a community around commercial EVs. Turno Battery Future is our solution to keeping batteries on the road for longer.
  • IASO Biotherapeutics — IASO Biotherapeutics (IASO BIO) is a Nanjing-based biopharmaceutical company focused on the discovery, development and commercialization of cell therapies in the field of oncology.
  • Huayuan Regenerative Medicine — Huayuan Regenerative Medicine is a developer of implantable biological artificial organs.
Show all investments...

Osaka University Venture Capital
VC Fund · Osaka, Osaka, Japan · 4 investments in Asia Life Science startups

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Japan

Investor stats

  • Total investments: 62
  • Round size: Seed $6.9M–$48M; Series A $17M–$233M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • SK Fine — SK Fine is the first to develop a 3D printer for ceramics and release it to the market for the first time in Japan.In addition, we are using 3D ceramic printers to develop 3D ceramic parts molding processes that meet our needs.
  • EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
  • GAIA BioMedicine — GAIA BioMedicine Inc., a spin-out venture from Kyushu University founded on 2015, is a technology-driven biopharmaceutical company focusing on cellular therapies and immunotherapies mainly for intractable malignancies.
Show all investments...

Huagai Capital
VC Fund · Beijing, Beijing, China · 4 investments in Asia Life Science startups, 9 in the past 12 months

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 110
  • Round size: Angel $412k–$1.3M; Series A $1.4M–$60M; Series B $3.5M–$90M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $430M in 2018

Portfolio highlights

  • Leo Summit — Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.
  • Leaf Biotech — Leaf Biotech is a research and development, production and sales of green chemical-related materials and series intermediates. The business produces biomass resources. The focus of the research and development is the bio-based polyester material PEF and important intermediates, as well as the creation of green drugs and intermediates for healthcareproducts.
  • Dingzhi Biotech — Dingzhi Biotech specialized in immunology and animal vaccine development. It focuses on innovative and large varieties in the research of covers poultry, livestock, and pets.
Show all investments...

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 3 investments in Asia Life Science startups, 59 in the past 12 months

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 487
  • Round size: Series A $4.1M–$48M; Series B $10M–$100M; Series C $16M–$148M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Atantares — We are a development stage startup enabling the next generation of precision medicine by fusing biochip and AI technologies.
  • Saints Sages Medical — Saints Sages Medical is engaged in the production and sales of minimally invasive surgical medical devices. They have several energy device products that are widely used in minimally invasive surgery, hepatobiliary surgery, gynecology, urology, thoracic surgery, and other departments. Saints Sages closely monitors clinical needs and develops moreinnovative minimally invasive surgical devices to serve global patients, relying on a professional research and development team and years of the clinical transformation experience.
  • Epigenic Therapeutics — Epigenic Therapeutics is a biotech firm that offers gene editing therapy.
Show all investments...

Legend Capital
VC Fund · Beijing, Beijing, China · 3 investments in Asia Life Science startups, 33 in the past 12 months

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 277
  • Round size: Series A $2.7M–$50M; Series B $11M–$110M; Series C $15M–$200M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
  • Saige Research — Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control. The company provides a deep learning vision inspection platform optimized for the manufacturing industry to solve inspectors' difficulties and increase work efficiency; its technology provides power detection, speed detection, wideversatility, and development convenience.
  • Ligatech Bioscience — Ligatech Bioscience is an intrusive consumables developer specializing in the development and manufacture of medical devices for the field of sports medicine, as well as the development and production of biomedical materials and products. A production line for artificial ligaments and artificial ligament fixation systems has been established. Andprovide users with relevant technical advice and technical services.
Show all investments...

Entrepreneurship Relay Group
VC Fund · Yangpu, Hainan, China · 3 investments in Asia Life Science startups

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Series A, Angel, Series C
  • Geography: China

Investor stats

  • Total investments: 6
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • ZStack — ZStack Cloud Platform has served more than 1,000 enterprise users and established ecological and channel partnerships with more than 200 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries.
  • Bangqi Biological — Bangqi Biological is a biotechnology company that focuses on the research and development, production, registration, quality, supply chain and sales of instruments and reagents for autoimmunity & allergy diagnosis.
  • Shanghai Bioprofile — Shanghai Bioprofile is a metabonomics technology service provider.
Show all investments...

EDBI
VC Fund · Singapore, Central Region, Singapore · 3 investments in Asia Life Science startups, 9 in the past 12 months

EDBI is a premier Asian investor with headquarters in Singapore.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series C, Series B, Series D
  • Geography: United States, Singapore, China

Investor stats

  • Total investments: 151
  • Round size: Series B $10M–$200M; Series C $7M–$350M; Series D $21M–$226M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Thunes — Payment infrastructure for a connected world.
  • Endowus — Licensed by MAS. Grow all your money through intelligent investment portfolios built by experts, customised to your goals. Award-winning fee-only wealth platform.
  • Automera — Automera focuses on a novel therapeutic methods to develop drugs.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Anzu Partners
VC Fund · Washington, District of Columbia, United States · 3 investments in Asia Life Science startups, 10 in the past 12 months

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Software
  • Stage:Series A, Series B
  • Geography: United States, Canada, Spain

Investor stats

  • Total investments: 68
  • Round size: Series A $872k–$14M; Series B $5M–$22M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Arduino — Arduino is an open-source electronics prototyping platform based on flexible, easy-to-use hardware and software. It's intended for artists, designers, hobbyists, and anyone interested in creating interactive objects or environments. Arduino created the worldwide trademark Genuino used as brand name outside the United States.
  • Aspinity — Aspinity offers neuromorphic all-analog integrated circuit technology that can replicate the functionality of digital signal processors. It reduces the system power requirements for always-on sensing applications.Their vision is that battery life does not have to stand in the way.It was founded in 2015 and headquartered in Pittsburgh,Pennsylvania.
  • South 8 Technologies — South 8 Technologies develops liquefied gas electrolyte chemistry for rechargeable lithium metal batteries and electrochemical capacitors.
Show all investments...

Mitsubishi UFJ Capital
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 9 in the past 12 months

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series B, Series A
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 259
  • Round size: Series A $11M–$96M; Series B $12M–$330M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
  • CADDi — CADDi is an online ordering platform for manufacturing industry.
  • EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
Show all investments...

SMBC Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 6 in the past 12 months

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Software
  • Stage:Series A, Series B
  • Geography: Japan, United States, Mexico

Investor stats

  • Total investments: 309
  • Round size: Series A $18M–$165M; Series B $21M–$357M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
  • Luup — Luup is an Internet Company.
  • Kyoto Fusioneering — Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors.
Show all investments...

Nippon Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Seed
  • Geography: Japan, United States

Investor stats

  • Total investments: 124
  • Round size: Seed $6.9M–$112M; Series A $6.8M–$82M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Utill — Utill is anything that expands the possibilities of not only production but also our own services
  • LIFESCAPES — LIFESCAPES is a research and manufacturer of brain-computer interface equipment.
  • LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 3 investments in Asia Life Science startups, 9 in the past 12 months

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Taiwan

Investor stats

  • Total investments: 76
  • Round size: Series A $2.7M–$41M; Series B $2.7M–$55M; Series C $14M–$58M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Xiguang Bio — Xiguang Bio focuses on the production of diagnostic reagents and provides chemiluminescent raw materials and overall system technology solutions.
  • Jiamuyao Medical — Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.
  • Panomic Biomedical Technology — Suzhou Panomic Biomedical Technology Co., Ltd. (BioNovoGene) was founded in Suzhou Industrial Park Bio-Nano Park in 2013. It is a leading high-tech enterprise focusing on metabolomics in China. Since its establishment, it has established a complete metabolomics detection and analysis platform - PanomicTM / Bionovogene, including metabolitepreprocessing platform, high-resolution mass spectrometry analysis platform, and metabolomics data analysis with independent intellectual property rights The system has perfect biomarker discovery capabilities and clinical application capabilities. The company's scientific research team has a rich background, covering biochemistry, bioinformatics, epidemiology and biostatistics, computer science, etc., and has a consultant team composed of top scientists and clinicians.
Show all investments...

ULTIMA
VC Fund · Chengdu, Sichuan, China · 2 investments in Asia Life Science startups

ULTIMA is an investment management firm.

Show more...

Investment focus

  • Industry: Hardware, Software, Agriculture
  • Stage:Angel, Series A
  • Geography: China

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Show all investments...

WuXi AppTec
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 42
  • Round size: Series A $5.9M–$90M; Series B $6.8M–$100M; Series C $30M–$40M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
  • Stemirna — Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, andgenetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.
Show all investments...

Highlight Capital
VC Fund · Nanjin, Jiangsu, China · 2 investments in Asia Life Science startups, 6 in the past 12 months

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Portugal

Investor stats

  • Total investments: 92
  • Round size: Series A $2.7M–$26M; Series B $2.7M–$70M; Series C $16M–$200M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Etana — PT Etana Biotechnologies Indonesia (Etana) is an emerging producer of high-quality, affordable and innovative biopharmaceuticals to treat a range of metabolic, autoimmune and other major life-threatening diseases, including cancer. Nathan Tirtana. Legend Capital. UOB Venture Management. Innovent Bio
  • Hongyixin — Hongyixin is an automotive electronic chip developer.
  • Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
Show all investments...

MiraclePlus
VC Fund · Haidian, Beijing, China · 2 investments in Asia Life Science startups, 14 in the past 12 months

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Angel, Pre-Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 56
  • Round size: Seed $200k–$3M; Angel $200k–$3M; Pre-Seed $300k–$2M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • YORG AI — Explore the future of work with YORG.AI
  • Zhongke Jiahe — Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.
  • Light Wheel Intelligence — Light Wheel Intelligence is offers automated, physically precise and controllable, real and generalizable synthetic data solutions to build AI data infrastructure,
Show all investments...

Eisai
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Asia Life Science startups

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series C
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 13
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
  • Ractigen Therapeutics — Early-stage pharma company creating first-in-class therapies boosting expression of therapeutic genes in diseased cells using saRNA.
  • LIFENET INSURANCE COMPANY — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Orient Securities Capital Investment
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups

Orient Securities Capital Investment is an private equity fund business platform.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Software
  • Stage:Series A, Series D, Series C
  • Geography: China

Investor stats

  • Total investments: 26
  • Round size: Series A $1.4M–$14M; Series D $49M–$69M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • HiStarlink — HiStarlink is a commercial company that makes communication technology like space-borne laser communication terminals and core devices. The main product matrix covers aerospace Advanced core optoelectronic devices, ultra-high-speed communication algorithms, laser communication terminals, and satellite-to-ground laser ground receiving systems.
  • Shiyu Precision — Shiyu Precision is a high-tech enterprise specializing in the research, development and manufacture of semiconductor automation equipment.
  • Soundcore Electronic Technology — Zhangjiagang Shengxin Electronic Technology Co., Ltd. is located in Huaxia Science and Technology Park, Zhangjiagang High-tech Industrial Development Zone. It was established on March 27, 2019 with a registered capital of 12 million yuan. It is an IDM enterprise integrating chip design, tape-out, packaging and testing. , with a complete industrialchain. The main products are: SAW RF chips and modules.
Show all investments...

Green Pine Capital Partners
VC Fund · Shenzhen, Guangdong, China · 2 investments in Asia Life Science startups, 7 in the past 12 months

Green Pine Capital Partners is a venture capital firm.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Manufacturing, Software
  • Stage:Series A, Angel, Series B
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 135
  • Round size: Angel $412k–$2.1M; Series A $1.4M–$89M; Series B $9.6M–$150M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $137M in 2019

Portfolio highlights

  • Biodep — Biodep produces probiotics and derivatives, which are used in meals, healthy foods, cosmetics, environmental remediation, contemporary agriculture, and other industries.
  • Readline — Readline is a biological immobilized enzyme catalysis technology application service provider.
  • Guorui Xiechuang — Guorui Xiechuang is a joint venture subsidiary of Betterray New Materials Group Co., Ltd., provides power + energy storage products and system integration solutions for global customers.
Show all investments...

Oriental Fortune Capital
VC Fund · Shenzhen, Guangdong, China · 2 investments in Asia Life Science startups, 18 in the past 12 months

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 166
  • Round size: Seed $412k–$41M; Series A $1.4M–$27M; Series B $2.7M–$100M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Microtreat — Microtreat specializes in the research, development, manufacturing, and sale of different high-end industrial application ultra-precision laser equipment, particularly equipment based on infrared, ultraviolet, green light, and ultra-short pulse technology, which is mostly utilized in the field of thin-film solar energy.
  • Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
  • Pinfeng Medical — Pinfeng Medical is a platform firm that integrates independent research and development, manufacturing, marketing, and service to provide high-quality intelligent testing and precise diagnostic solutions to the local and international in vitro diagnostic industries.
Show all investments...

Nissay Capital
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Asia Life Science startups

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Show more...

Investment focus

  • Industry: Health Care, Internet, Medical
  • Stage:Seed, Series A
  • Geography: Japan, United States

Investor stats

  • Total investments: 147
  • Round size: Seed $925k–$55M; Series A $14M–$69M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Todoker — Todoker is a baggage delivery convenient service providing company.
  • LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
  • Beer and Tech — Beer and Tech operates a website for the Phalaenopsis or foliage plant HitoHana. Norihisa Morita and Yoshiaki Ito founded it in 2014, with its headquarters in Saitama in Japan.
Show all investments...

Loyal Valley Capital
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups

Loyal Valley Capital (LVC) is a thematic, research-driven private equity firm with strong entrepreneurial culture that invests in middle market companies positioned to benefit from the secular industry transformations in China. With over US$1.6 billion of assets under management, LVC mainly focuses on the following segments: Consumer (TMT,Internet, and Education), Healthcare, and Advanced Manufacturing. Our investment process is characterized by in-depth top-down and bottom-up fundamental research to uncover secular themes and utilize extensive industry mapping to deploy capital in a high conviction and disciplined approach. We pride ourselves as a trusted influential shareholder relentlessly focused on active value creation and accelerating growth via strategic initiatives through our extensive network of business leaders in China. LVC manages capital on behalf of international institutional investors such as sovereign wealth funds, funds of funds, private banks, and family offices, as well as elite entrepreneurs and founders of China’s Fortune 500 enterprises.LVC was founded in 2015 by Andy Lin, an experienced investor and accomplished entrepreneur. He is the founder of China Universal Asset Management (“CUAM”), one of China’s largest equity investor and asset manager with over US$100B in AUM, known for its industry leading research and award-winning investment records.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series C, Series B, Series A
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 76
  • Round size: Series A $14M–$279M; Series B $25M–$137M; Series C $33M–$220M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Chabaidao — Chabaidao is a tea drink brand that aims to create surprises through product development and trendy gameplay.
  • Jinyuansheng — Jinyuansheng is mainly engaged in the development, smelting and deep processing of new energy key metal mineral resources.
  • Medilink Therapeutics — MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.
Show all investments...

BOHE Angel Fund
VC Fund · Suzhou, Jiangsu, China · 2 investments in Asia Life Science startups

BOHE Angel Fund is an investment Fund.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Angel, Seed, Series A
  • Geography: China

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • Levostar — Levostar is a biotechnology company that specializes in the development and manufacture of cell and gene therapy products.
  • Singlomics — Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.
  • Shuimu BioSciences — Shuimu BioSciences Ltd. was founded in 2017 in Beijing, China, to bring the power of Cryo-EM to new therapeutics developers through a differentiated service offering, making the method accessible and affordable for Discovery teams at all stages of method adoption. We are the first commercial full service Cryo-EM platform in Asia, led by top expertsfrom Tsinghua University and experienced industry executives. All of our work is performed with the quality controls and service levels expected of a top tier contract research organization.
Show all investments...

CentreGold Capital
VC Fund · Fremont, California, United States · 2 investments in Asia Life Science startups

Our team invests in early-stage digital health and consumer startups at CentreGold Capital.

Show more...

Investment focus

  • Industry: Internet, Medical Device, Artificial Intelligence
  • Stage:Seed, Series A, Angel
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 15
  • Round size: Seed $549k–$3M; Series A $1.8M–$2.1M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Fantuan — Order food with Fantuan Delivery. Get the best Asian food delivered to your door from your favorite local restaurants. Everyday promotion.
  • IOT Pay — Omni Channel Payment Solution
  • Saltalk — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.
Show all investments...

Incubate Fund
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Asia Life Science startups, 7 in the past 12 months

Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Seed, Series A
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 180
  • Round size: Seed $500k–$45M; Series A $11M–$165M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: Likely still investing — raised $2.3B in 2021

Portfolio highlights

  • Cerby — Collaborate without chaos. Cerby helps your team be productive while protecting your brand. Secure unmanageable applications. Only with Cerby.
  • CYBO — CYBO provides products and services to understand cells deeply and to harness them widely.
  • Bondy — Bondy is an HR Tech automation platform that specializes in connecting different HR processes.
Show all investments...

Mizuho Capital
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Asia Life Science startups, 10 in the past 12 months

Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.

Show more...

Investment focus

  • Industry: Information Technology, Software, Internet
  • Stage:Series A, Series B
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 264
  • Round size: Series A $7.8M–$130M; Series B $25M–$343M
  • Lead/follow: 2% lead, 98% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • Funds — Funds is an online marketplace for lending funds.
  • Bloomo Investment — Bloomo Investment is a software company that specializes in the development of smart and fun investment apps.
  • LexxPluss — LexxPluss develops an automatic transfer software system and robot hardware.
Show all investments...

SBI Investment
VC Fund · Minato, Chiba, Japan · 2 investments in Asia Life Science startups, 13 in the past 12 months

SBI Investment supports the business development and growth of private venture companies through fund investment.

Show more...

Investment focus

  • Industry: Financial Services, Information Technology, Software
  • Stage:Series B, Series A
  • Geography: Japan, South Korea, United States

Investor stats

  • Total investments: 232
  • Round size: Series A $6M–$179M; Series B $5.9M–$302M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — raised $1.1B in 2020

Portfolio highlights

  • Edgecortix — At Edgecortix, we automate the design of AI accelerators for on-device deep learning. Our Dynamic Neural Accelerator IP, and performance optimized AI Software & Hardware Co-exploration framework, reduces time to market and brings massive cost savings across multiple industry verticals.
  • Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
  • Captain Fresh — Captain Fresh is a freshwater fish and seafood supply chain platform. Captain Fresh is a B2B marketplace leveraging technology to deliver the fastest harvest-to-retail in the industry. The company focuses on aggregating the fragmented retail demand across the country and linking them to the small fishermen and farmers throughout the Indian coast.The company was founded in 2019 and is based in Bengaluru, India.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Huimei Capital
VC Fund · Beijing, Beijing, China · 2 investments in Asia Life Science startups

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 26
  • Round size: Series A $10M–$220M; Series B $56M–$96M; Series C $30M–$69M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Sensview — Sensview specializes in the development and production of solid-state imaging chips and detector modules.
  • Bio-Engine — Bio-Engine is a developer of high-density serum-free suspension culture technology for animal cells. Its main products include HEK293 cell serum-free medium, PK15 cell serum-free medium, etc., which can be applied to antibodies, recombinant proteins, human and livestock. Virus vaccine, cell therapy and other fields.
  • Zilixir Biotech — Zilixir Biotech develops a new protein design technology that offers possibilities for human exploration of the complex life sciences. SWORD™ protein design technology integrates binding pockets, new drug skeleton design, activity prediction, ADME/T prediction, etc., and has had some achievements in these areas, fully demonstrating theeffectiveness of protein design.
Show all investments...

Sherpa Venture Capital
VC Fund · Beijing, Beijing, China · 2 investments in Asia Life Science startups

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Kenya

Investor stats

  • Total investments: 64
  • Round size: Series A $6.9M–$38M; Series B $14M–$74M; Series C $19M–$151M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
  • Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
  • Danking Pharmaceuticals — Danking Medicine is an innovation-driven drug developer.
Show all investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups, 7 in the past 12 months

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Angel
  • Geography: China, United States

Investor stats

  • Total investments: 51
  • Round size: Angel $412k–$14M; Series A $1.4M–$15M; Series B $6.9M–$34M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Kanova — Kanova is a biopharmaceutical firm.
  • Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Show all investments...

Senshu Ikeda Capital
VC Fund · Osaka, Osaka, Japan · 2 investments in Asia Life Science startups

Senshu Ikeda Capital offers financial consultancy services.

Show more...

Investment focus

  • Industry: Software, Internet, Information Technology
  • Stage:Seed, Series A
  • Geography: Japan

Investor stats

  • Total investments: 47
  • Round size: Seed $5.6M–$59M; Series A $16M–$89M
  • Lead/follow: 6% lead, 94% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2019

Portfolio highlights

  • Sagri — Sagri is developing agriculture software for experienced farmers.
  • BABY JOB — BABY JOB offers nursery support and child care support businesses.
  • On The Slope — On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.
Show all investments...

Eight Roads Ventures
VC Fund · London, England, United Kingdom · 2 investments in Asia Life Science startups, 22 in the past 12 months

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, India

Investor stats

  • Total investments: 309
  • Round size: Series A $5.4M–$62M; Series B $7.3M–$100M; Series C $13M–$100M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $350M in 2022

Portfolio highlights

  • Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
  • New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Show all investments...

Bits x Bites
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups

Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Series A, Seed, Series B
  • Geography: China, Israel, Singapore

Investor stats

  • Total investments: 27
  • Round size: Seed $4k–$20M; Series A $412k–$38M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
  • Mojia Bioscience — Mojia Bioscience is a biotechnology company.
  • Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.
Show all investments...

Real Tech Japan
VC Fund · Sumida, Tokyo, Japan · 2 investments in Asia Life Science startups

Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Robotics
  • Stage:Series A, Seed
  • Geography: Japan, Singapore, Austria

Investor stats

  • Total investments: 76
  • Round size: Seed $4.8M–$41M; Series A $6M–$233M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • ProfilePrint — ProfilePrint synthesises complex molecular data of ingredient samples into digital fingerprints, rapidly predicting its identity and quality, helping agribusinesses to buy and sell better with its patented digital food identity-as-a-service (IDaaS) technology.
  • Integriculture — Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable cleanmeat.Founded in 2015, Integriculture is headquartered in Tokyo, Japan.
  • Sentient.io — We provide a secure AI & Data platform with ready-made AI models for easy adoption and turnkey AI solutions for Enterprises on your digitalisation journey.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 52
  • Round size: Seed $8M–$21M; Series A $2.7M–$20M; Series B $11M–$50M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
  • Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
  • Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups, 21 in the past 12 months

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 163
  • Round size: Series A $11M–$69M; Series B $21M–$100M; Series C $27M–$275M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Akura Medical — Akura Medical is developing a next-generation thrombectomy device that aims to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots.
  • Precede Biosciences — Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. Discover how we are helping create a world where medicine is developed more successfully, and every diagnosis is precise and minimally invasive.
  • LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Show all investments...

Lucion
VC Fund · Jinan, Shandong, China · 2 investments in Asia Life Science startups, 9 in the past 12 months

Lucion is an influential professional venture capital institute.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Manufacturing
  • Stage:Series A, Seed, Series B
  • Geography: China

Investor stats

  • Total investments: 32
  • Round size: Series A $1.4M–$522M; Series B $2.7M–$21M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Best Ray — Bolui Laser is a high tech enterprises that focuses on independent research and development and industrialization of high-end lasers and laser applications. It offers clients h innovative solutions in the fields of industrial processing, cutting-edge scientific research, environmental monitoring, semiconductors, radar remote sensing, etc. andcompetitive products and advanced laser technology solutions to continue to create value for customers.
  • Tage Zhixing — Beijing Tage Zhixing Technology Co., Ltd. is a high-tech enterprise focusing on mining vehicle unmanned driving technology research, product development, and overall engineering solution design and implementation of unmanned mines. Tage Zhixing has launched a car-ground-cloud collaborative smart mine unmanned transportation system, which realizescloud intelligent dispatching management, 4G.
  • Xinhuan Technology — Xinhuan Technology specializes in advanced cardiovascular interventional, natural cavity imaging and advanced diagnostic procedures.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
ASBV
VC Fund · Shenzhen, Guangdong, China · 2 investments in Asia Life Science startups

ASBV focuses on early and mid-term venture capital investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China

Investor stats

  • Total investments: 17
  • Round size: Angel $412k–$412k; Series A $1.4M–$30M
  • Lead/follow: 71% lead, 29% follow

Portfolio highlights

  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Huasaiboman Medical Cell Biology — Warseeberman is a cell therapy solution provider, focusing on new cell therapy technologies, based on clinical research, and dedicated to the development of immune cell drug products for the treatment of solid tumors and stem cell therapy products for the treatment of degenerative diseases. The company aims at the cutting-edge technology of tumorimmunotherapy, focuses on the development of tumor infiltrating lymphocyte (TIL) drugs for solid tumors, and cooperates with many hospitals to establish a solid tumor and clinical transformation research institute, dedicated to bringing life to solid tumor patients Hope.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Show all investments...

Anhui High-tech Industry Investment
VC Fund · Hefei, Anhui, China · 1 investments in Asia Life Science startups

Anhui High-tech Industry Investment is engaged in high-tech industry investment and related derivative business.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Angel
  • Geography: China

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • GENERAL BIOL — GENERAL BIOL is a biotechnology and life science service provider company.
Show all investments...

Tsing-Yuan Capital
VC Fund · Shenzhen, Guangdong, China · 1 investments in Asia Life Science startups

Tsing-Yuan Capital is a Chinese venture capital firm specialized in early, middle, and mature stage investments.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, E-Commerce
  • Stage:Series A, Angel, Series B
  • Geography: China, United States

Investor stats

  • Total investments: 43
  • Round size: Angel $412k–$412k; Series A $1.4M–$14M; Series B $2.7M–$14M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Soundec — Soundec is an enterprise that focuses on acoustic research and commercialization. The company's products include modules containing software algorithms and audio processing chips, which are mainly used in wired digital headphones and Bluetooth wireless headphones.
  • cheaptrustedpharmacy — 4B Technologies is a biotech company that develops novel medicines for neurodegenerative diseases and neurological injuries. Its drug development focuses on reliving pain symptoms from nervous system diseases such as stroke and glaucoma, enabling healthcare professionals to prescribe more effective treatments to their patients.The company wasfounded in 2017 and is based in Suzhou, China.
  • Yishi Technology — Yishi Technology is a 3D vision laser sensor R&D manufacturer dedicated to the research and development of intelligent industrial cameras
Show all investments...

Kaitai Capital
VC Fund · Hangzhou, Zhejiang, China · 1 investments in Asia Life Science startups

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Angel, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 91
  • Round size: Seed $1.4M–$20M; Angel $412k–$14M; Series A $1.4M–$21M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Chiplego — Chiplego focuses on embedded high-performance computing systems that assist in the creation of a mobile digital world and a better travel and life experience for everyone.
  • Levinthal — Levinthal is an AI-driven protein design platform. They offer services for artificial intelligence in food safety and medical care. They offer synthetic biology, food, feed, and environmental protection.
  • Xihu Xinchen — Xihu Xinchen is a technology company focusing on the research and development of artificial intelligence services.
Show all investments...

SDIC Venture Capital
VC Fund · Xicheng, Hebei, China · 1 investments in Asia Life Science startups, 16 in the past 12 months

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion.SDICVC puts into practice the marketization and industrializationof the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 84
  • Round size: Series A $8.2M–$76M; Series B $2.7M–$275M; Series C $14M–$56M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Yanming Biology — Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
  • Dehui Electronics — Dehui Electronics develops, manufactures, and sells high-performance electronic ceramics and related electronic components.
  • Huaxun Semiconductor — Huaxun Semiconductor is a high-tech firm specialized in R&D, production, and distribution of essential materials for advanced integrated circuit packaging.The company focuses on providing system solutions and key materials for ultra-thin wafer processing and holding, ultra-thin device manufacturing, three-dimensional stack packaging, flexibledisplay, conductive interconnection, and other fields, guided by the lightness, thinness, and shortness of integrated circuits.
Show all investments...

Hiroaki Kitano
Angel · 1 investments in Asia Life Science startups

Hiroaki Kitano is the SVP at Softbank Mobile. He attended Waseda University.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Fitness
  • Stage:Seed, Angel, Debt Financing
  • Geography: Japan, United States

Investor stats

  • Total investments: 6
  • Round size: Seed $6.9M–$41M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GPx — GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.The company was founded in 2020and is based in Boston, Massachusetts.
  • Epistra — Epistra accelerates research and development in life sciences.
  • Activaid — Activaid owns and operates a social data platform for patients with inflammatory bowel disease. It allows patients to support and exchange information within the patient community with the same disease; provide information necessary for new drug development and matching to clinical trials that suits them; and improve medical treatment. YasuakiHasebe founded Activaid in 2018. It has its headquarters in Tokyo in Japan.
Show all investments...

Alibaba Group
VC Fund · Hangzhou, Zhejiang, China · 1 investments in Asia Life Science startups, 11 in the past 12 months

Alibaba Group’s mission is to make it easy to do business anywhere. They enable businesses to transform the way they market, sell, operate, and improve their efficiencies. They provide the technology infrastructure and marketing reach to help merchants, brands, and other businesses to leverage the power of new technology to engage with theirusers and customers and operate in a more efficient way.Their businesses are comprised of core commerce, cloud computing, digital media and entertainment, and innovation initiatives. In addition, Ant Financial, a company in which they have agreed to acquire a 33% equity stake, provides payment and financial services to consumers and merchants on their platforms. An ecosystem has developed around their platforms and businesses that consists of consumers, merchants, brands, retailers, other businesses, third-party service providers, and strategic alliance partners.

Show more...

Investment focus

  • Industry: E-Commerce, Internet, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 164
  • Round size: Series A $1.4M–$600M; Series B $6M–$300M; Series C $17M–$400M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Mirauge3D — Mirauge3D is a fully automatic, efficient, 2D and 3D integrated image intelligent modeling system. They offer software that supports multi-core parallel processing architectures and GPU cluster computing.
  • Lazada Group — Lazada is the number one online shopping and selling destination in Southeast Asia – present in Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam. Lazada helps more than 100,000 local and international sellers, as well as 2,500 brands, serve the 560 million consumers in the region through its marketplace platform, supportedby a wide range of tailored marketing, data, and service solutions. Lazada offers an excellent customer experience through a wide network of logistics partners and it's own first- and last-mile
  • Jiecheng New Energy — Jiecheng New Energy is a new energy material recycling service provider.
Show all investments...

Kunlun Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Asia Life Science startups

Kunlun Capital is a value-oriented and fundamentally driven family office. We do not manage external funds.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Genetics
  • Stage:Seed, Series A, Series B
  • Geography: China

Investor stats

  • Total investments: 9
  • Round size: Seed $20M–$27M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • UniXell — UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
  • Ningbo Shanshan — Ningbo Shanshan engaged in the research and development, manufacture and distribution of lithium battery materials.
  • Zhongke Digital — ## Build Setup
Show all investments...

Fujifilm
VC Fund · Tokyo, Tokyo, Japan · 1 investments in Asia Life Science startups

Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, Medical
  • Stage:Series A, Series B
  • Geography: Japan, Israel, United States

Investor stats

  • Total investments: 10
  • Round size: Series A $49M–$412M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
  • Nanox Imaging — Nanox Vision develops a next-generation medical imaging system based on groundbreaking technology. Our aim is to democratize medical imaging and bring preventive healthcare to communities worldwide, helping create a better standard of care for all.
  • 24M Technologies — 24M Technologies develops energy storage systems for grid and transportation applications. 24M Technologies, Inc. builds energy storage systems for grid and transportation applications. The company was founded in 2010 and is based in Cambridge, Massachusetts.
Show all investments...

Hana Financial Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Asia Life Science startups, 7 in the past 12 months

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Show more...

Investment focus

  • Industry: Information Technology, FinTech, Financial Services
  • Stage:Series A, Seed
  • Geography: South Korea, Singapore, India

Investor stats

  • Total investments: 40
  • Round size: Seed $860k–$2.5M; Series A $2.7M–$25M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Trustay — Trustay is a real estate asset management company.
  • AIZEN Global — AIZEN is redesigning Digital Banking with CreditConnect, powered by our proprietary ABACUS AutoML platform specialized in the financial services industry. CreditConnect is an AI lending platform designed to bridge the gap between banks and data economy platforms, and automate key decision-making processes in accordance with the credit cycle. Thecompany has secured Series B round funding from a state-led fintech innovation fund (K-Growth) led by major Korean banks to roll out CreditConnect in Southeast Asia.We are also leading the digital transformation in the financial services industry using proprietary AutoML platform ABACUS, with successful use cases in underwriting, fraud detection, product development, claim analysis, and more.
  • Kuntian New Energy — Hebei Kuntian New Energy is a producer of anode materials for lithium-ion batteries.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 investors investing in Asia Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists